Norbert Claude Gorin
About
In The Last Decade
Norbert Claude Gorin
185 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 4.4k
- Oncology 1.9k
- Genetics 1.5k
- Public Health, Environmental and Occupational Health 1.5k
- Immunology 1.0k
Countries citing papers authored by Norbert Claude Gorin
This map shows the geographic impact of Norbert Claude Gorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Claude Gorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Claude Gorin more than expected).
Fields of papers citing papers by Norbert Claude Gorin
This network shows the impact of papers produced by Norbert Claude Gorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Claude Gorin. The network helps show where Norbert Claude Gorin may publish in the future.
Co-authorship network of co-authors of Norbert Claude Gorin
This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Claude Gorin. A scholar is included among the top collaborators of Norbert Claude Gorin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Claude Gorin. Norbert Claude Gorin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 22 | |
| 6 | A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission | 1 |
| 7 | Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT | 1 |
| 8 | 31 | |
| 9 | 105 | |
| 10 | 9 | |
| 11 | 360 | |
| 12 | Comparative Outcome of Reduced Intensity and Myeloablative Preparative Regimen in HLA Identical Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years of Age with Acute Myeloblastic Leukaemia: A Retrospective Survey from the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT). | 1 |
| 13 | 3 | |
| 14 | Rôle de l’hémobiologiste dans un service d’hématologie : bonnes pratiques de transfusion clinique | 2 |
| 15 | 18 | |
| 16 | 24 | |
| 17 | 43 | |
| 18 | 26 | |
| 19 | Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. | 134 |
| 20 | A propos de l'association: leucémie myéloïde chronique, sarcome ganglionnaire. Etude de deux nouveaux cas. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.